The Association of American Medical Colleges (AAMC) and the Council on Governmental Relations (COGR) submitted joint comments to the DEA in support of the proposed...
Cannabis/Controlled Substances
Regulatory requirements associated with clinical and non-clinical research on Schedule I and II Controlled Substances (including cannabis) and issues arising from differences between state and federal laws governing cannabis research.
Featured
COGR Submits Response to Congressional RFI on Federal Regulation of CBD Products
COGR submitted comments in response to a federal Request for Information regarding cannabidiol (CBD). COGR’s letter emphasizes the importance of continued research...
COGR Responds to HHS Notice of Proposed Rulemaking “Confidentiality of Substance Abuse Disorder Patient Records”
COGR, representing over 200 U.S. research institutions, submitted comments on the Department of Health and Human Services' proposed rule to align the confidentiality...
Resources
Point of Contact
Kristin West
Director, Research Ethics & Compliance
All Cannabis/Controlled Substances Articles
COGR and AAMC Submit Joint Letter to DEA on Rescheduling Marijuana
The Association of American Medical Colleges (AAMC) and the Council on Governmental Relations (COGR) submitted joint comments to the DEA in support of the proposed rescheduling of marijuana from Schedule I to Schedule III under the Controlled Substances Act, highlighting that this shift would reduce barriers and administrative burdens for cannabis research at their member institutions. They recomm
COGR Submits Response to Congressional RFI on Federal Regulation of CBD Products
COGR submitted comments in response to a federal Request for Information regarding cannabidiol (CBD). COGR’s letter emphasizes the importance of continued research into the safety and effectiveness of CBD and other cannabinoids, noting that ambiguous and restrictive federal regulations currently hinder scientific advancements in this area. The organization describes the difficulties that researche
COGR Responds to HHS Notice of Proposed Rulemaking “Confidentiality of Substance Abuse Disorder Patient Records”
COGR, representing over 200 U.S. research institutions, submitted comments on the Department of Health and Human Services' proposed rule to align the confidentiality regulations for substance abuse disorder patient records (42 CFR Part 2) with HIPAA. COGR supports the alignment to reduce dual compliance burdens and enhance research capabilities, advocating for clearer allowances for creating de-id
COGR and AAMC Submit Joint Comment Letter to NIH on Cannabis RFI (NOT-AT-22-026)
The letter jointly submitted by the Association of American Medical Colleges (AAMC) and the Council on Governmental Relations (COGR) responds to an NIH Request for Information concerning barriers to researching the health effects of cannabis and its constituents. The organizations emphasize their support for increased federal efforts to assess the therapeutic potential of cannabinoid and cannabis-
COGR Submits Letter to DEA in Regard to Federal Register Notice, "Controls to Enhance the Cultivation of Marihuana for Research in the United States
The Council on Governmental Relations (COGR), representing 187 major U.S. research institutions, submitted comments to the DEA regarding the proposed controls to enhance the cultivation of marijuana for research purposes. COGR expressed appreciation for the DEA’s steps toward expanding the pool of authorized cannabis manufacturers beyond the current single supplier, highlighting the necessity for
COGR Submits Letter to USDA on Hemp Rules
The Council on Governmental Relations (COGR), representing 188 research universities and affiliated institutions, submitted formal comments on the USDA’s Interim Final Rule (IFR) for establishing a U.S. domestic hemp production program. The letter acknowledges USDA’s efforts to clarify the legal status of hemp transportation and commerce but highlights several regulatory concerns adversely affecti
COGR Letter to SAMHSA on New Attestation Requirements
The Council on Governmental Relations (COGR), representing a consortium of research universities and affiliated institutions, submitted a formal letter to SAMHSA expressing significant concerns regarding a newly required attestation for grant recipients. This attestation demands that institutions certify not only the proper use of grant funds in accordance with federal law—namely, not using funds
Joint Association Letter on Industrial Hemp
COGR, the Association of American Universities, and the Association of Public and Land-grant Universities sent this letter to congressional leaders to advocate for the inclusion of Senate provisions in the final 2018 Farm Bill that would remove federal regulatory barriers to industrial hemp research. Specifically, they request explicit federal guidance allowing university researchers to obtain, gr
COGR Submits Letter to DEA Regarding Production Quotas for Schedule I & II Controlled Substances
COGR submitted formal comments to the U.S. Drug Enforcement Administration (DEA) regarding the proposed 2019 aggregate production quotas for Schedule I and II controlled substances, with particular attention to marijuana and its derivatives. COGR expressly supports the proposed increase in production quotas for marijuana and tetrahydrocannabinols, seeing this as a constructive move to advance scie
